1887
  1. Home
  2. Eurosurveillance
  3. Volume 22, Issue 42, 19/Oct/2017
  4. Article
Editorial Open Access
Like 0
Download
Preview this article:
Preview Magnify

There is no abstract available.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.42.17-00698
2017-10-19
2024-04-19
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.42.17-00698
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/42/eurosurv-22-42-1.html?itemId=/content/10.2807/1560-7917.ES.2017.22.42.17-00698&mimeType=html&fmt=ahah

References

  1. McCormack S. After PROUD…. 9th IAS Conference on HIV Science (IAS 2017). Presentation number SUSA0704. Paris. 23 Jul 2017. Available from: http://programme.ias2017.org/People/PeopleDetailStandalone/19
  2. Grullich A. Taking PrEP to scale for gay and bisexual men in Australia. 9th IAS Conference on HIV Science (IAS 2017). Presentation number SUSA0705. Paris. 23 Jul 2017. Available from: http://www.aidsmap.com/London-gonorrhoea-rates-fall-and-HIV-rates-falling-in-Australia-as-more-join-PrEP-demo/page/3158470/
  3. Government of New South Wales. NSW HIV Strategy 2016 – 2020. April - June 2017. Data Report. North Sydney: Government of New South Wales. [Accessed Oct 2017]. Available from: http://www.health.nsw.gov.au/endinghiv/Documents/q2-2017-nsw-hiv-data-report.pdf
  4. European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2015. Stockholm: ECDC; 2016. Available from: https://ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2015
  5. McCormack SM, Noseda V, Molina JM. PrEP in Europe - expectations, opportunities and barriers. J Int AIDS Soc. 2016;19(7(Suppl 6)) Suppl 6;21103. PMID: 27760681 
  6. Hoornenborg E, Krakower DS, Prins M, Mayer KH. Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries. AIDS. 2017;31(16):2179-91.  https://doi.org/10.1097/QAD.0000000000001627  PMID: 28991023 
  7. San Francisco Community Clinic Consortium (SFCCC). San Francisco’s. “Getting to Zero” Initiative and HIV Pre-exposure Prophylaxis (PrEP). San Francisco: SFCCC; 27 Dec 2016. Available from: https://www.sfccc.org/featured-stories/2016/12/27/updates-from-san-franciscos-getting-to-zero-initiative
  8. Ong KJ, Desai S, Field N, Desai M, Nardone A, van Hoek AJ, et al. Economic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016. Euro Surveill. 2017;22(42):pii=17-00192. https://doi.org/10.2807/1560-7917.ES.2017.22.42.17-00192
  9. Cambiano V, Miners A, Dunn D, McCormack S, Gill N, Nardone A, et al. Is pre-exposure prophylaxis for HIV prevention cost-effective in men who have sex with men who engage in condomless sex in the UK? Sex Transm Infect. 2015;91(Suppl 1):A1.  https://doi.org/10.1136/sextrans-2015-052126.1 
  10. Nichols BE, Boucher CAB, van der Valk M, Rijnders BJA, van de Vijver DAMC. Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study. Lancet Infect Dis. 2016;16(12):1423-9.  https://doi.org/10.1016/S1473-3099(16)30311-5  PMID: 27665989 
  11. Schneider K, Gray RT, Wilson DP. A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia. Clin Infect Dis. 2014;58(7):1027-34.  https://doi.org/10.1093/cid/cit946  PMID: 24385445 
  12. Juusola JL, Brandeau ML, Owens DK, Bendavid E. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med. 2012;156(8):541-50.  https://doi.org/10.7326/0003-4819-156-8-201204170-00001  PMID: 22508731 
  13. Durand-Zaleski I, Mutuon P, Charreau I, Temblay C, Rojas D, Chas J, et al. Cost effectiveness of on demand PrEP in men who have sex with men (MSM) in the ANRS IPERGAY study. 21st International AIDS Conference. Durban, South Africa. 18-22 Jul 2016. [Abstract THAW304].
  14. Landers S, Kapadia F. Preexposure Prophylaxis: Adapting HIV Prevention Models to Achieve Worldwide Access. Am J Public Health. 2017;107(10):1534-5.  https://doi.org/10.2105/AJPH.2017.304035  PMID: 28902562 
  15. Avert. Norway provides PrEP for free to all those at risk of HIV. Avert: Brighton; 14 Nov 2016. Available from: https://www.avert.org/news/norway-provides-prep-free-all-those-risk-hiv
  16. Scotland HIV. PrEP FAQs. Edinburgh: HIV Scotland. [Accessed 11 Oct 2017]. Available from: http://www.hivscotland.com/our-work/prep-in-scotland/prep-faqs/
  17. NAM AIDS Map. Belgium, Portugal and Brazil will provide PrEP through their health services; Morocco announces a PrEP study. London: NAM. 5 Jun 2017. Available from: http://www.aidsmap.com/Belgium-Portugal-and-Brazil-will-provide-PrEP-through-their-health-services-Morocco-announces-a-PrEP-study/page/3144551/
  18. European AIDS Treatment Group (EATG). PrEP access in Europe. PrEP in Europe initiative (PiEi). Brussels: EATG. 2016. Available from: http://www.eatg.org/wp-content/uploads/2016/10/PrEP-access-in-Europe-PrEP-in-Europe-Initiative-PiEi.pdf
  19. European Medicines Agency (EMA). European public assessment reports (EPAR) for human medicines. London: EMA. [Accessed 11 Oct 2017]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124
  20. i-Base. Generic PrEP in France and Scotland challenges access across the UK. London: i-Base.1 Oct 2017. Available from: http://i-base.info/htb/32501
  21. World Bank. Tayler Y. Battling HIV/AIDS A Decision Maker's Guide to the Procurement of Medicines and Related Supplies. Jun 2004. https://doi.org/10.1596/0-8213-5848-0
  22. World Trade Organization (WTO), World Intellectual Property Organization (WIPO), World Health Organization (WHO). Promoting access to medical technologies and innovation. Geneva: WTO; 2012. Available from: https://www.wto.org/english/res_e/booksp_e/pamtiwhowipowtoweb13_e.pdf
  23. Australian Federation of AIDS Organisations (AFAO). National Association of people with HIV Australia (NAPWHA). Joint submission to the Senate Standing Committees on Community Affairs. Therapeutic Good Amendment (2016 Measures No. 1) Bill 2016. Newtown: AFAO. [Accessed 11 Oct 2017]. Available from: https://www.afao.org.au/wp-content/uploads/2016/12/2017-03_AFAO-and-NAPWHA-Submission-Therapeutic-Goods-Amendment-2016-Measures-No-1-Bill-2016-3-March-2017.pdf
  24. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53-60.  https://doi.org/10.1016/S0140-6736(15)00056-2  PMID: 26364263 
  25. Public Health England (PHE). NHS England. Update on PrEP Impact trial in England. London: PHE; 10 Apr 2017. Available from: https://www.gov.uk/government/news/update-on-prep-impact-trial-in-england
  26. United Kingdom intellectual property office The Legislative Reform (Patents) Order 2014. [Accessed 11 Oct 2017]. Available from: http://www.legislation.gov.uk/uksi/2014/1997/pdfs/uksiod_20141997_en.pdf
  27. The Wall Street Journal. Mylan to Provide Generic Truvada for U.K. Trial. The Wall Street Journal. 3 Aug 2017. Available from: https://www.wsj.com/articles/mylan-to-provide-generic-truvada-for-u-k-trial-1501783891
  28. Zorginstituut Nederland. Medicijnkosten.nl. [Medicine Costs]. Diemen: Zorginstituut Nederland. [Accessed 11 Oct 2017]. Dutch. Available from: https://www.medicijnkosten.nl/databank?medicijnId=4585&niveau=2
  29. College ter Beoordeling van Geneesmiddelen. Geneesmiddeleninformatiebank. [Medicines Information Bank]. Utrecht: College ter Beoordeling van Geneesmiddelen. [Accessed 11 Oct 2017]. Dutch. Available from: https://db.cbg-meb.nl/ords/f?p=111:2:0:SEARCH:NO:RP%2C2:P0_DOMAIN%2CP0_LANG%2CP2_QS%2CP2_AS_PROD%2CP2_AS_RVGNR%2CP2_AS_EU1%2CP2_AS_EU2%2CP2_AS_ACTSUB%2CP2_AS_INACTSUB%2CP2_AS_NOTINACT%2CP2_AS_ADDM%2CP2_AS_ARMM%2CP2_AS_APPDATE%2CP2_AS_APPDATS%2CP2_AS_ATC%2CP2_AS_PHARM%2CP2_AS_MAH%2CP2_AS_ROUTE%2CP2_AS_AUTHS%2CP2_AS_TGTSP%2CP2_AS_INDIC%2CP2_AS_TXTF%2CP2_AS_TXTI%2CP2_AS_TXTC%2CP2_RESPAGE%2CP2_SORT%2CP2_RESPPG:H%2CNL%2C%5Cemtricitabine%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2CN%2CN%2CN%2C%2C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C%5C%5C%2C1%2CPRODA%2C100
  30. The Health Council of the Netherlands. [Internet]. The Hague. [Accessed 11 Oct 2017]. Available from: https://www.gezondheidsraad.nl/en
  31. Overheid.nl. Gemeente Amsterdam. Instemmen met het gewijzigde initiatiefvoorstel “Ondersteuning van informeelPrEP gebruik” van de leden Roosma en Vroege en kennisnemen van debestuurlijke reactie op het oorspronkelijke voorstel. (2017, nr. 233/866). Agendapunt 31A. Gemeenteblad. Nr. 145195. 18 augustus 2017. [Agreement on the modified initiative “Supporting Informal PrEP use”]. Zoetermeer: Overheid. 19 Apr 2017. Available from: https://zoek.officielebekendmakingen.nl/gmb-2017-145195.html
  32. IwantPrEPnow (IWPN). [Internet]. London: Terrence Higgins Trust. [Accessed 11 Oct 2017]. Available from: https://www.iwantprepnow.co.uk/
  33. Deutsche Aidshilfe. PrEP will soon be available for 50 Euros in Germany, starting in seven cities. Berlin: Deutsche Aidshilfe. Sept 2017. Available from: https://www.aidshilfe.de/meldung/prep-will-soon-available-50-euros-germany-starting-seven-cities
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error